Signpostcancerdx
The startup develops laboratory-based diagnostic tests utilizing artificial intelligence, algorithms, and epigenomic profiling to detect all major subtypes of breast cancer from stage 1 to 4. With a sensitivity and specificity of 98.5%, their tests enable early and accurate cancer diagnosis, improving treatment outcomes for patients.
Traction –/10
Kingston, Jamaica · HQ
- Artificial Intelligence
- Digital Health
- Healthcare Technology
- Software Only
Updated 5 months ago
Funding
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops laboratory-based diagnostic tests utilizing artificial intelligence, algorithms, and epigenomic profiling to detect all major subtypes of breast cancer from stage 1 to 4. With a sensitivity and specificity of 98.5%, their tests enable early and accurate cancer diagnosis, improving treatment outcomes for patients.